Glenmark Pharmaceuticals Ltd, said it appointed Dr Penelope (Penny) Ward as its new president for clinical research and development (R&D) and chief medical officer.
Dr Ward will be based at Glenmark’s Clinical R&D centre at Oxford in UK. She will oversee the entire clinical development activity for both new chemical entities (NCEs) and new biological entities (NBEs), the company said in a regulatory filing.
Currently, Glenmark has eight programs in clinical development of which six are NCEs and two are NBEs. In her role as chief medical officer, Dr Ward will also guide all medical activities across Glenmark's branded generic markets.
On Thursday, Glenmark ended 0.5% down at Rs264 on the Bombay Stock Exchange, while the benchmark Sensex closed 1.7% up at 17,022 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )